HBI Deals+Insights / Digital and AI

Isomorphic Labs raises $2.1bn 

Isomorphic Labs, a London-based AI drug design and development company, has raised $2.1 billion in funding led by American venture capital firm Thrive Capital. Google Ventures. Tech giant Alphabet's independent venture capital arm, alongside specialist technology investment firm MGX, global investment firm Temasek, Alphabet's independent growth equity fund CapitalG, and the UK Sovereign AI Fund, the British government’s £500 million ($670.32 mn) venture fund, also invested in the firm.